Header Logo

Connection

DAVID BATES to Bevacizumab

Back to Details
This is a "connection" page, showing publications DAVID BATES has written about Bevacizumab.
DAVID BATES
Connection Strength
0.435
Bevacizumab
  1. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance. Mol Oncol. 2015 Jan; 9(1):167-78.
    View in: PubMed
    Score: 0.435
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.